AV
The startup develops a rapid medical testing device that detects the enzyme thymidine kinase in blood samples from dogs, cats, and horses, indicating tumor growth associated with cancer. This technology enables early cancer detection, allowing veterinarians and pet owners to initiate treatment before clinical symptoms appear.
Updated 3 months ago
Funding
$810K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a rapid medical testing device that detects the enzyme thymidine kinase in blood samples from dogs, cats, and horses, indicating tumor growth associated with cancer. This technology enables early cancer detection, allowing veterinarians and pet owners to initiate treatment before clinical symptoms appear.